Literature DB >> 27659696

Newly Proposed Prognostic Grade Group System for Prostate Cancer: Genesis, Utility and its Implications in Clinical Practice.

Makarand Khochikar1.   

Abstract

We know about the Gleason pattern and Gleason score which are of paramount importance in tailoring the treatment of a prostate cancer. However, there are certain deficiencies in this current scoring system. To simplify the treatment options and have a better idea about the prognosis, a new grade group system has been proposed by ISUP/WHO in 2015. This has been validated in the clinical practice. This commentary takes you through its genesis, utility and its implications on the clinical practice.

Entities:  

Keywords:  Active survelliance; Gleason score; Grade group; Prostate cancer

Mesh:

Year:  2016        PMID: 27659696     DOI: 10.1007/s11934-016-0635-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  10 in total

Review 1.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

2.  Gleason score 6 adenocarcinoma: should it be labeled as cancer?

Authors:  H Ballentine Carter; Alan W Partin; Patrick C Walsh; Bruce J Trock; Robert W Veltri; William G Nelson; Donald S Coffey; Eric A Singer; Jonathan I Epstein
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

3.  Consensus guidelines for reporting prostate cancer Gleason Grade.

Authors:  Anthony Zietman; Joseph Smith; Eric Klein; Michael Droller; Prokar Dasgupta; James Catto
Journal:  BJU Int       Date:  2016-06       Impact factor: 5.588

Review 4.  Histologic grading of prostate cancer: a perspective.

Authors:  D F Gleason
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

Review 5.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

Review 6.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

7.  Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer.

Authors:  Mark A Rubin; Gabriele Girelli; Francesca Demichelis
Journal:  Eur Urol       Date:  2015-11-10       Impact factor: 20.096

8.  Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

Authors:  Phillip M Pierorazio; Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

9.  Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.

Authors:  Stacy Loeb; Yasin Folkvaljon; David Robinson; Ingela Franck Lissbrant; Lars Egevad; Pär Stattin
Journal:  Eur Urol       Date:  2015-12-17       Impact factor: 20.096

10.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

Authors:  Jonathan I Epstein; Michael J Zelefsky; Daniel D Sjoberg; Joel B Nelson; Lars Egevad; Cristina Magi-Galluzzi; Andrew J Vickers; Anil V Parwani; Victor E Reuter; Samson W Fine; James A Eastham; Peter Wiklund; Misop Han; Chandana A Reddy; Jay P Ciezki; Tommy Nyberg; Eric A Klein
Journal:  Eur Urol       Date:  2015-07-10       Impact factor: 20.096

  10 in total
  1 in total

1.  Histopathological Study of the Prostate Cancer Growth Patterns in Relation with the Grading Systems.

Authors:  Tudor Cristian Timotei Popescu; Alex Emilian Stepan; Mirela Marinela Florescu; Cristiana Eugenia Simionescu
Journal:  Curr Health Sci J       Date:  2022-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.